| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |